ID: ALA542712

Max Phase: Preclinical

Molecular Formula: C17H17ClN8

Molecular Weight: 332.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)c1ccc2[nH]c(Cc3nc4cc(C(=N)N)ccc4[nH]3)nc2c1

Standard InChI:  InChI=1S/C17H16N8.ClH/c18-16(19)8-1-3-10-12(5-8)24-14(22-10)7-15-23-11-4-2-9(17(20)21)6-13(11)25-15;/h1-6H,7H2,(H3,18,19)(H3,20,21)(H,22,24)(H,23,25);1H

Standard InChI Key:  DAYQQTRNIVUDTR-UHFFFAOYSA-N

Associated Targets(Human)

Tryptase beta-1 295 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypsin I 2306 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Thrombin & trypsin 271 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.37Molecular Weight (Monoisotopic): 332.1498AlogP: 1.60#Rotatable Bonds: 4
Polar Surface Area: 157.10Molecular Species: BASEHBA: 4HBD: 6
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 8#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.94CX Basic pKa: 11.30CX LogP: -0.22CX LogD: -4.06
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.25Np Likeness Score: -0.63

References

1. Costanzo MJ, Yabut SC, Almond HR, Andrade-Gordon P, Corcoran TW, De Garavilla L, Kauffman JA, Abraham WM, Recacha R, Chattopadhyay D, Maryanoff BE..  (2003)  Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.,  46  (18): [PMID:12930148] [10.1021/jm030050p]

Source